Geode Capital Management, LLC Abbott Laboratories Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Geode Capital Management, LLC holds 33,733,715 shares of ABT stock, worth $3.49 Billion. This represents 0.36% of its overall portfolio holdings.

Number of Shares

33,733,715

Previous 32,853,400 2.68%

Holding current value

$3.49 Billion

Previous $3.62 Billion 6.03%

% of portfolio

0.36%

Previous 0.38%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$109.52 - $120.96 $96.4 Million - $106 Million	880,315 Added 2.68%	33,733,715 $3.83 Billion
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $38.8 Million - $47.5 Million	429,981 Added 1.33%	32,853,400 $3.62 Billion
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $52 Million - $62.4 Million	544,462 Added 1.71%	32,423,419 $3.14 Billion
Q2 2023 Aug 11, 2023	BUY	$100.78 - $112.29 $68.7 Million - $76.6 Million	682,169 Added 2.19%	31,878,957 $3.48 Billion
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $57.9 Million - $68.2 Million	598,164 Added 1.95%	31,196,788 $3.16 Billion

Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $51.1 Million - $60 Million	537,808 Added 1.79%	30,598,624 $3.35 Billion
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $63.2 Million - $73.2 Million	653,535 Added 2.22%	30,060,816 $2.91 Billion
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $87.4 Million - $106 Million	856,450 Added 3.0%	29,407,281 $3.19 Billion
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $73.5 Million - $89.6 Million	644,549 Added 2.31%	28,550,831 $3.37 Billion
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $89.8 Million - $110 Million	776,993 Added 2.86%	27,906,282 $3.92 Billion
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $80.7 Million - $89.3 Million	691,934 Added 2.62%	27,129,289 $3.2 Billion
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $48.1 Million - $56.6 Million	454,618 Added 1.75%	26,437,355 $3.05 Billion
Q1 2021 May 12, 2021	BUY	$108.84 - $128.23 $37.2 Million - $43.8 Million	341,890 Added 1.33%	25,982,737 $3.1 Billion
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $38.4 Million - $41.9 Million	366,080 Added 1.45%	25,640,847 $2.8 Billion
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $3.31 Million - $4.01 Million	36,073 Added 0.14%	25,274,767 $2.74 Billion
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $30 Million - $38.3 Million	391,238 Added 1.57%	25,238,694 $2.3 Billion
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $9.82 Million - $14.4 Million	-156,369 Reduced 0.63%	24,847,456 $1.96 Billion
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $25.9 Million - $28.9 Million	330,243 Added 1.34%	25,003,825 $2.17 Billion
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $44.6 Million - $48.4 Million	544,880 Added 2.26%	24,673,582 $2.06 Billion
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $13.3 Million - $15.5 Million	182,823 Added 0.76%	24,128,702 $2.03 Billion
Q1 2019 May 14, 2019	BUY	$66.22 - $80.06 $120 Million - $145 Million	1,811,894 Added 8.19%	23,945,879 $1.91 Billion
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $117 Million - $132 Million	1,778,840 Added 8.74%	22,133,985 $1.6 Billion
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $21.8 Million - $26.3 Million	358,242 Added 1.79%	20,355,145 $1.49 Billion
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $45.5 Million - $50.2 Million	789,837 Added 4.11%	19,996,903 $1.22 Billion
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $64.8 Million - $73.2 Million	1,150,705 Added 6.37%	19,207,066 $1.15 Billion
Q4 2017 Feb 13, 2018	BUY	$53.68 - $57.47 $42.6 Million - $45.6 Million	794,027 Added 4.6%	18,056,361 $1.03 Billion
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $20.2 Million - $22.6 Million	420,709 Added 2.5%	17,262,334 $919 Million
Q2 2017 Aug 14, 2017	BUY	N/A	16,841,625	16,841,625 $817 Million

Others Institutions Holding ABT

# of Institutions

3,126

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $181B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Abbott Laboratories Transaction History